These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34971077)

  • 1. The longest reported sibling survivors of a severe form of congenital myasthenic syndrome with the ALG14 pathogenic variant.
    Katata Y; Uneoka S; Saijyo N; Aihara Y; Miyazoe T; Koyamaishi S; Oikawa Y; Ito Y; Abe Y; Numata-Uematsu Y; Takayama J; Kikuchi A; Tamiya G; Uematsu M; Kure S
    Am J Med Genet A; 2022 Apr; 188(4):1293-1298. PubMed ID: 34971077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital myasthenic syndromes due to mutations in ALG2 and ALG14.
    Cossins J; Belaya K; Hicks D; Salih MA; Finlayson S; Carboni N; Liu WW; Maxwell S; Zoltowska K; Farsani GT; Laval S; Seidhamed MZ; ; Donnelly P; Bentley D; McGowan SJ; Müller J; Palace J; Lochmüller H; Beeson D
    Brain; 2013 Mar; 136(Pt 3):944-56. PubMed ID: 23404334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of congenital myasthenic syndrome caused by a novel compound heterozygous variant in RAPSN.
    Saito M; Ogasawara M; Inaba Y; Osawa Y; Nishioka M; Yamauchi S; Atsumi K; Takeuchi S; Imai K; Motobayashi M; Misawa Y; Iida A; Nishino I
    Brain Dev; 2022 Jan; 44(1):50-55. PubMed ID: 34565654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and genetic characteristics of congenital myasthenia syndrome with episodic apnea caused by CHAT gene mutation: a report of 2 cases].
    Liu ZM; Fang F; Ding CH; Zhang WH; Deng J; Chen CH; Wang X; Liu J; Li Z; Jia XL; Zeng JS; Qian SY
    Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):216-220. PubMed ID: 29518833
    [No Abstract]   [Full Text] [Related]  

  • 5. A Novel Homozygous Variant in the CHRNE Gene in 2 Siblings with Congenital Myasthenic Syndrome.
    Chan C; Emery L; Maltese C; Kumar A; Aliu E; Naik S; Paul D
    Child Neurol Open; 2023; 10():2329048X231216432. PubMed ID: 38034490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital Myasthenic Syndrome associated with acetylcholine receptor deficiency: case report and review of the literature.
    Batheja A; Bayer-Vile J; Silverstein E; Couser N
    Ophthalmic Genet; 2024 Oct; 45(5):481-487. PubMed ID: 38832364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital Myasthenic Syndromes in 2018.
    Engel AG
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):46. PubMed ID: 29892917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy.
    Nicole S; Chaouch A; Torbergsen T; Bauché S; de Bruyckere E; Fontenille MJ; Horn MA; van Ghelue M; Løseth S; Issop Y; Cox D; Müller JS; Evangelista T; Stålberg E; Ioos C; Barois A; Brochier G; Sternberg D; Fournier E; Hantaï D; Abicht A; Dusl M; Laval SH; Griffin H; Eymard B; Lochmüller H
    Brain; 2014 Sep; 137(Pt 9):2429-43. PubMed ID: 24951643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK.
    Gallenmüller C; Müller-Felber W; Dusl M; Stucka R; Guergueltcheva V; Blaschek A; von der Hagen M; Huebner A; Müller JS; Lochmüller H; Abicht A
    Neuromuscul Disord; 2014 Jan; 24(1):31-5. PubMed ID: 24183479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.
    Belaya K; Rodríguez Cruz PM; Liu WW; Maxwell S; McGowan S; Farrugia ME; Petty R; Walls TJ; Sedghi M; Basiri K; Yue WW; Sarkozy A; Bertoli M; Pitt M; Kennett R; Schaefer A; Bushby K; Parton M; Lochmüller H; Palace J; Muntoni F; Beeson D
    Brain; 2015 Sep; 138(Pt 9):2493-504. PubMed ID: 26133662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital myasthenic syndrome: a tale of two siblings.
    Banerjee A; Datta Kanjilal S; Biswas T; Ghoshal A; Sarkar S
    Int J Neurosci; 2024 Jun; 134(3):253-255. PubMed ID: 36018836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VAMP1-Related Congenital Myasthenic Syndrome: A Case Report and Literature Review.
    Yıldırım M; Yarenci GB; Genç MB; Uçar Çİ; Bayav S; Tekin MN; Bektaş Ö; Teber S
    Neuropediatrics; 2024 Jun; 55(3):200-204. PubMed ID: 38531369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and lethal neurodegeneration with myasthenic and myopathic features: A new
    Schorling DC; Rost S; Lefeber DJ; Brady L; Müller CR; Korinthenberg R; Tarnopolsky M; Bönnemann CG; Rodenburg RJ; Bugiani M; Beytia M; Krüger M; van der Knaap M; Kirschner J
    Neurology; 2017 Aug; 89(7):657-664. PubMed ID: 28733338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypical and Myopathological Consequences of Compound Heterozygous Missense and Nonsense Variants in
    Della Marina A; Arlt A; Schara-Schmidt U; Depienne C; Gangfuß A; Kölbel H; Sickmann A; Freier E; Kohlschmidt N; Hentschel A; Weis J; Czech A; Grüneboom A; Roos A
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and neurophysiological characteristics of congenital myasthenic syndromes presenting in early infancy.
    Zafeiriou DI; Pitt M; de Sousa C
    Brain Dev; 2004 Jan; 26(1):47-52. PubMed ID: 14729415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants of
    Lamond A; Buckley D; O'Dea J; Turner L
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare slow channel congenital myasthenic syndromes without repetitive compound muscle action potential and dramatic response to low dose fluoxetine.
    Durmus H; Sticht H; Ceylaner S; Hashemolhosseini S; Deymeer F
    Acta Neurol Belg; 2021 Dec; 121(6):1755-1760. PubMed ID: 33030681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital myasthenic syndromes in childhood: diagnostic and management challenges.
    Kinali M; Beeson D; Pitt MC; Jungbluth H; Simonds AK; Aloysius A; Cockerill H; Davis T; Palace J; Manzur AY; Jimenez-Mallebrera C; Sewry C; Muntoni F; Robb SA
    J Neuroimmunol; 2008 Sep; 201-202():6-12. PubMed ID: 18707767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New compound heterozygous variants of the cholinergic receptor nicotinic delta subunit gene in a Chinese male with congenital myasthenic syndrome: A case report.
    Feng H; Zhou H
    Medicine (Baltimore); 2017 Dec; 96(51):e8981. PubMed ID: 29390429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new patient with congenital myasthenic syndrome type 20 due to compound heterozygous missense SLC5A7 variants suggests trends in genotype-phenotype correlation.
    Vlckova M; Prchalova D; Zimmermann P; Haberlova J; Bendova S; Moslerova V; Stranecky V; Sedlacek Z; Hancarova M
    Mol Genet Genomic Med; 2023 Jun; 11(6):e2154. PubMed ID: 36840359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.